Regeneus Ltd. (AU:CMB) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Cambium Bio Limited, a Sydney-based regenerative medicine firm, has fortified its leadership by appointing ocular immunology expert Dr. Louis Tong to its Scientific Advisory Board and pharmaceutical veteran Dr. ChiTai Chang to its Board of Directors. These strategic appointments are set to bolster the company’s scientific expertise and strategic business development as it advances its lead product, Elate Ocular®, targeting dry eye disease. The company is focused on ophthalmic and tissue repair therapeutics, with a commitment to ushering its clinical pipeline to market.
For further insights into AU:CMB stock, check out TipRanks’ Stock Analysis page.